



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
A comprehensive overview of amyotrophic lateral sclerosis (als), also known as lou gehrig's disease. It explores the causes, prevalence, symptoms, diagnosis, treatments, and outlook of als, focusing on its impact on the affected system. Genetic and environmental factors linked to als, its prevalence, symptoms such as muscle weakness and respiratory failure, diagnosis methods like electromyography and mri, and treatment options like pharmaceuticals and care management. It emphasizes the importance of early detection and comprehensive care for individuals with als, despite the current limited treatment options.
Typology: Essays (university)
1 / 6
This page cannot be seen from the preview
Don't miss anything!
Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrigs disease is a condition that affects the motor neurons, in the brain and spinal cord. It results in paralysis, muscle weakness and respiratory failure. This essay aims to explore the causes, prevalence, symptoms, diagnosis, treatments and outlook of ALS with a focus on its impact on the system. Causes : The exact cause of ALS remains unknown although several factors have been linked to its origins. Genetic mutations in genes like SOD1, C9orf72 and TARDBP have been found in cases of ALS indicating a predisposition. Environmental influences such as exposure to toxins and heavy metals may also contribute to cases of ALS (Mehta et al., 2022). Dysfunctions in processes like protein aggregation, oxidative stress and mitochondrial dysfunction likely play a role in the progression of ALS by causing degeneration of motor neurons. Prevalence: With an estimated prevalence rate of 2 to 3 cases, per 100,000 individuals ALS is considered a rare disease. It typically manifests between ages forty and seventy. Can occur at any
age. The chances of developing ALS are higher, in men than in women. While a small percentage of cases have a link most occur randomly suggesting a vulnerability. Symptoms and Signs: One of the characteristics of ALS is progressive muscle weakness, which may initially manifest as clumsiness or difficulty with precise movements. Patients might notice muscle shrinkage involuntary muscle twitches known as fasciculations and increased muscle stiffness as the disease progresses. Weakness typically starts in the limbs. Can affect muscle groups like those involved in speaking, swallowing and breathing. Individuals may also experience slurred speech (dysarthria) difficulty swallowing (dysphagia) and breathing problems that can lead to health issues. Diagnosis: Identifying ALS can be difficult since it involves ruling out conditions with symptoms like spinal cord compression, multiple sclerosis and muscular disorders. A thorough neurological exam along with tests such as electromyography (EMG) nerve conduction studies and imaging techniques like MRI are often used to evaluate motor function and rule out causes (Tsai & Manley 2021). Genetic testing might also be conducted to pinpoint
To sum up ALS is a condition characterized by the gradual breakdown of motor neurons leading to muscle weakness, paralysis and respiratory problems. While its exact causes are not fully understood genetic and environmental factors likely play a role in its development. Early detection and comprehensive care are essential for improving outcomes for individuals with ALS even though treatment options are currently limited. Further research into the underlying mechanisms of ALS is crucial, for developing therapies and enhancing patient outcomes. Picture 1: Electromyography (EMG) test
Picture 2: MRI of the brain showing motor cortex atrophy Reference Mehta, P. R., Iacoangeli, A., Opie-Martin, S., van Vugt, J. J., Al Khleifat, A., Bredin, A., ... & Al-Chalabi, A. (2022). The impact of age on genetic testing decisions in amyotrophic lateral sclerosis. Brain, 145(12), 4440-4447. Tsai, Y. L., & Manley, J. L. (2021). Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death. Cell Cycle, 20(7), 631-646.